Summary Information:
Vivos Therapeutics Inc. Common Stock
NASDAQ:VVOS


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Vivos Therapeutics Inc. Common Stock
Exchange: NASDAQ
Symbol: VVOS
SEC CIK: 0001716166
Phone: (866)908-4867
9137 RIDGELINE BOULEVARD
SUITE 135
HIGHLANDS RANCH CO 80129
CEO:
Price when page updated: 17.1441 Date: 2023-12-02
Company Website:
www.vivoslife.com

_Description: Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep disordered breathing, including obstructive sleep apnea (OSA). Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Combining technologies and protocols that alter the size, shape and position of the tissues of the upper human airway, the Vivos System opens airway space and can eliminate or significantly reduce symptoms and conditions associated with mild-to-moderate OSA. The Vivos System has been shown to significantly lower Apnea Hypopnea Index scores and improve other conditions associated with OSA. Sales of the Vivos System are driven by the Vivos Integrated Practice (VIP) program, which offers dentists training and value-added services in connection with their use of the Vivos System.

IPO YEAR:
2020
Sector:
Health Care
Industry:
Medical Specialities
ADRTSO:

MarketCap:
20525911.00
Beta:
1.786868551477957
52 Week High:
10.86
52 Week Low:
2.18
52 Week Change:
-0.6324961715160797
Short Interest:

Short Date:

Shares Outstanding:
23012119
Dividend Rate:
0
Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
14 Nov 2022
Float:
0
return on Equity:
-77.70%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
-$22.29
ttmEPS:
0
Revenue:
$16.897M
Gross Profit:

Cash:

Debt:

Institution Percent:
9.20%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
0.10%
Return on Assets:
-59.60%
Return on Capital:

Profit Margin:
-
Price to Sales:
0.99
Price To Book:
0.80
Short Ratio:
4.05
PE Ratio:
0
Employees:
115
1Y Guesstimate
3.183:4.0:6




__The following are links to various summary and news pages for
__Vivos Therapeutics Inc. Common Stock [ VVOS ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-12-02